Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
HSR26-224: Clinical and Predictive Utility of the Khorana Score in High-Risk Solid Tumors: A 10-Year Cohort Study.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 16, 2026
HSR26-224: Clinical and Predictive Utility of the Khorana Score in High-Risk Solid Tumors: A 10-Year Cohort Study.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 31, 2026
Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 07, 2025
Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS Data.
Journal: Transplantation and cellular therapy
Published: August 29, 2024
Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database.
Journal: Transplantation and cellular therapy
Published: April 26, 2024
Testing of an Ultrasound-Limited Imaging Protocol for Pavlik harness Supervision (TULIPPS) in developmental dysplasia of the hip: a randomized controlled trial.
Journal: The bone & joint journal
Published: September 01, 2022
Hematological and infectious complications with CD38 antigen targeting monoclonal antibody-based therapies in multiple myeloma: A meta-analysis of randomized control trials.
Journal: Leukemia research
Published: July 29, 2021
Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report.
Journal: International journal of antimicrobial agents
Published: June 28, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026